Method based on GC-MS to study the influence of tricarboxylic acid cycle metabolites on cardiovascular risk factors

Journal of Pharmaceutical and Biomedical Analysis
M Calderón-SantiagoM D Luque de Castro

Abstract

Metabolites involved in the tricarboxylic acid (TCA) cycle have previously been proposed as cardiovascular biomarkers. This cycle plays a key role in cell metabolism and the levels of the involved metabolites can also be affected by other physiological factors. The influence of three cardiovascular risk factors such as obesity, hypercholesterolemia, and smoking habit on serum levels of TCA-cycle metabolites has been studied in patients diagnosed with significant coronary lesion. For this purpose, a method based on GC-MS for determination of the target metabolites (viz. citric/isocitric, pyruvic, aconitic, oxaloacetic, malic, fumaric and succinic acids) in serum has been developed. The high accuracy and throughput analysis featuring the method have allowed application to a cohort of 223 patients, 172 of them with significant coronary lesion. Multifactor analysis of variance has revealed interactions between the occurrence or not of a coronary lesion and the risk factors considered in this study. These interactions were crucial to explain the levels of target TCA metabolites. Statistical evaluation by ROC curves allowed discrimination of the capability of significant metabolites with the occurrence of coronary lesions.

References

Sep 1, 1984·Journal of the Neurological Sciences·H J GreenD A Ranney
Apr 12, 2000·Acta Physiologica Scandinavica·M J GibalaH Taegtmeyer
Jun 29, 2000·Journal of Hypertension·N S DhallaT Netticadan
Nov 15, 2000·Journal of Epidemiology and Community Health·A LanghammerL Bjermer
Oct 14, 2004·Journal of Agricultural and Food Chemistry·Alireza GhassempourNahid Mashkouri Najafi
Dec 14, 2005·Circulation·Marc S SabatineRobert E Gerszten
Dec 15, 2005·Analytical Chemistry·Jiye AThomas Moritz
Jan 24, 2007·Acta neurochirurgica·G StranjalisA D Mendelow
Aug 2, 2007·PloS One·Ryan J MaillouxVasu D Appanna
Jul 24, 2008·Advanced Drug Delivery Reviews·Stanley Muravchick
Jan 28, 2009·Analytical and Bioanalytical Chemistry·M VallejoC Barbas
Mar 19, 2011·BMC Bioinformatics·Xavier RobinMarkus Müller
Aug 13, 2011·International Journal of Oncology·C Echiburú-ChauG M Calaf
Sep 10, 2011·Journal of Proteome Research·Patrizia BerniniAdriana Tognaccini

❮ Previous
Next ❯

Citations

Mar 10, 2015·Comparative Biochemistry and Physiology. Part D, Genomics & Proteomics·Bo-Young LeeJae-Seong Lee
May 29, 2016·Breast Cancer Research : BCR·Michelle N HarvieAnthony Howell
Jan 31, 2017·International Journal of Molecular Sciences·Diana González-PeñaConcepción Sánchez-Moreno
Jul 31, 2019·Clinical Cardiology·Xuesi DongGaoxiang Ma
Oct 18, 2018·Mediators of Inflammation·Anna Hernández-AguileraJorge Joven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.